Roles of Opioid Receptor Subtype in the Spinal Antinociception of Selective Cyclooxygenase 2 Inhibitor
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background:Selective inhibitors of cyclooxygenase (COX)-2 are commonly used analgesics in various pain conditions. Although their actions are largely thought to be mediated by the blockade of prostaglandin (PG) biosynthesis, evidences suggesting endogenous opioid peptide link in spinal antinociception of COX inhibitor have been reported. We investigated the roles of opioid receptor subtypes in the spinal antinociception of selective COX-2 inhibitor. Methods:To examine the antinociception of a selective COX-2 inhibitor, DUP-697 was delivered through an intrathecal catheter, 10 minutes before the formalin test in male Sprague-Dawley rats. Then, the effect of intrathecal pretreatment with CTOP, naltrindole and GNTI, which are m, d and k opioid receptor antagonist, respectively, on the analgesia induced by DUP-697 was assessed. Results:Intrathecal DUP-697 reduced the flinching response evoked by formalin injection during phase 1 and 2. Naltrindole and GNTI attenuated the antinociceptive effect of intrathecal DUP-697 during both phases of the formalin test. CTOP reversed the antinociception of DUP-697 during phase 2, but not during phase 1. Conclusions:Intrathecal DUP-697, a selective COX-2 inhibitor, effectively relieved inflammatory pain in rats. The d and k opioid receptors are involved in the activity of COX-2 inhibitor on the facilitated state as well as acute pain at the spinal level, whereas the m opioid receptor is related only to facilitated pain. (Korean J Pain 2010; 23: 236-241)
Abstract
Background:Selective inhibitors of cyclooxygenase (COX)-2 are commonly used analgesics in various pain conditions. Although their actions are largely thought to be mediated by the blockade of prostaglandin (PG) biosynthesis, evidences suggesting endogenous opioid peptide link in spinal antinociception of COX inhibitor have been reported. We investigated the roles of opioid receptor subtypes in the spinal antinociception of selective COX-2 inhibitor. Methods:To examine the antinociception of a selective COX-2 inhibitor, DUP-697 was delivered through an intrathecal catheter, 10 minutes before the formalin test in male Sprague-Dawley rats. Then, the effect of intrathecal pretreatment with CTOP, naltrindole and GNTI, which are m, d and k opioid receptor antagonist, respectively, on the analgesia induced by DUP-697 was assessed. Results:Intrathecal DUP-697 reduced the flinching response evoked by formalin injection during phase 1 and 2. Naltrindole and GNTI attenuated the antinociceptive effect of intrathecal DUP-697 during both phases of the formalin test. CTOP reversed the antinociception of DUP-697 during phase 2, but not during phase 1. Conclusions:Intrathecal DUP-697, a selective COX-2 inhibitor, effectively relieved inflammatory pain in rats. The d and k opioid receptors are involved in the activity of COX-2 inhibitor on the facilitated state as well as acute pain at the spinal level, whereas the m opioid receptor is related only to facilitated pain. (Korean J Pain 2010; 23: 236-241)
참고문헌 (22)
- Herrero JF, "Reversal by naloxone of the spinal antinociceptive actions of a systemically-administered NSAID", Br J Pharmacol, 118, pp.968~972 (1996)
- Troullos E, "Ibuprofen elevates immunoreactive beta-endorphin levels in humans during surgical stress", Clin Pharmacol Ther, 62, pp.74~81 (1997)
- Michel RE, "Ketorolac causes the release of methionine-enkephalin in rats", Res Commun Mol Pathol Pharmacol, 91, pp.249~252 (1996)
- França DS, "Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo- oxygenase 2 in rat paws treated with carrageenan", Neuropharmacology, 51, pp.37~43 (2006)
- Yaksh TL, "Chronic catheterization of the spinal subarachnoid space", Physiol Behav, 17, pp.1031~1036 (1976)
- 최정일, "백서를 이용한 포르말린 시험하에서 척수강내 Gabapentin의 항침해작용에 대한 Serotonergic 수용체의 영향", The Korean Journal of Pain, 15(1), pp.19~25 (2002), 대한통증학회
- Jones RM, "5'-Guanidinonaltrindole, a highly selective and potent kappa-opioid receptor antagonist", Eur J Pharmacol, 396, pp.49~52 (2000)
- Seibert K, "Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney", Br J Pharmacol, 117, pp.1016~1020 (1996)
- Raynor K, "Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors", Mol Pharmacol, 45, pp.330~334 (1994)
- Yoon MH, "Roles of opioid receptor subtypes on the antinociceptive effect of intrathecal sildenafil in the formalin test of rats", Neurosci Lett, 441, pp.125~128 (2008)
- Puig S, "Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity", Pain, 64, pp.345~355 (1996)
- Nishiyama T, "Analgesic effects of intrathecally administered celecoxib, a cyclooxygenase-2 inhibitor, in the tail flick test and the formalin test in rats", Acta Anaesthesiol Scand, 50, pp.228~233 (2006)
- Domer F, "Characterization of the analgesic activity of ketorolac in mice", Eur J Pharmacol, 177, pp.127~135 (1990)
- Pini LA, "Naloxone-reversible antinociception by paracetamol in the rat", J Pharmacol Exp Ther, 280, pp.934~940 (1997)
- Rezende RM, "The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids", Pain, 142, pp.94~100 (2009)
- Herrero JF, "The effects of sham and full spinalization on the systemic potency of mu- and kappa- opioids on spinal nociceptive reflexes in rats", Br J Pharmacol, 104, pp.166~170 (1991)
- Taiwo YO, "Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses", J Neurosci, 8, pp.1346~1349 (1988)
- Koetzner L, "Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2", J Neurosci, 24, pp.1451~1458 (2004)
- Riley RC, "Spinal release of immunoreactive dynorphin A(1-8) with the development of peripheral inflammation in the rat", Brain Res, 710, pp.131~142 (1996)
- Iadarola MJ, "Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization", Brain Res, 455, pp.205~212 (1988)
- Sandrini M, "The effect of paracetamol on nociception and dynorphin A levels in the rat brain", Neuropeptides, 35, pp.110~116 (2001)
- Zollner C, "Painful inflammation-induced increase in mu- opioid receptor binding and G-protein coupling in primary afferent neurons", Mol Pharmacol, 64, pp.202~210 (2003)